B cell and anti-PLA2R antibody-guided rituximab therapy in idiopathic membranous nephropathy: a prospective multi-center cohort study in the East Coastal Region of China. This evidence concerns the gene PLA2R1 and idiopathic membranous glomerulonephritis.